CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
50.48
0.00 (0.00%)
Nov 13, 2026, 12:58 PM EST - Market open
CONMED Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,504 | 1,257 | 2,114 | 3,368 | 2,702 | 4,146 | |
Market Cap Growth | 8.66% | -40.53% | -37.22% | 24.64% | -34.83% | 29.43% |
Enterprise Value | 2,272 | 2,072 | 3,017 | 4,350 | 3,705 | 4,830 |
Last Close Price | 50.48 | 40.60 | 67.70 | 107.19 | 86.12 | 136.67 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.96 | 26.72 | 15.97 | 52.25 | - | 66.29 |
Forward PE | 10.96 | 9.42 | 14.72 | 26.27 | 28.25 | 40.05 |
PS Ratio | 1.10 | 0.92 | 1.62 | 2.71 | 2.58 | 4.10 |
PB Ratio | 1.42 | 1.22 | 2.20 | 4.04 | 3.62 | 5.28 |
P/FCF Ratio | 11.34 | 8.33 | 13.74 | 31.68 | 233.33 | 42.79 |
P/OCF Ratio | 10.28 | 7.37 | 12.66 | 26.87 | 80.98 | 37.10 |
PEG Ratio | 2.14 | 2.77 | 0.96 | 1.43 | 2.85 | 2.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.66 | 1.51 | 2.31 | 3.50 | 3.54 | 4.78 |
EV/EBITDA Ratio | 10.57 | 10.28 | 13.13 | 23.09 | 23.97 | 27.26 |
EV/EBIT Ratio | 16.20 | 16.12 | 18.94 | 36.81 | 42.51 | 44.01 |
EV/FCF Ratio | 17.13 | 13.73 | 19.60 | 40.92 | 319.97 | 49.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.77 | 0.86 | 0.98 | 1.19 | 1.44 | 0.90 |
Debt / EBITDA Ratio | 3.61 | 4.17 | 3.97 | 5.05 | 6.62 | 3.81 |
Debt / FCF Ratio | 6.15 | 5.88 | 6.16 | 9.32 | 92.70 | 7.27 |
Net Debt / Equity Ratio | 0.72 | 0.82 | 0.96 | 1.16 | 1.40 | 0.87 |
Net Debt / EBITDA Ratio | 3.57 | 4.20 | 4.02 | 5.13 | 6.76 | 3.86 |
Net Debt / FCF Ratio | 5.79 | 5.61 | 6.00 | 9.10 | 90.20 | 7.06 |
Asset Turnover | 0.59 | 0.59 | 0.57 | 0.54 | 0.52 | 0.57 |
Inventory Turnover | 1.70 | 1.81 | 1.73 | 1.75 | 1.67 | 2.08 |
Quick Ratio | 0.61 | 0.92 | 0.94 | 0.86 | 0.74 | 1.04 |
Current Ratio | 1.49 | 2.14 | 2.30 | 1.98 | 1.96 | 2.34 |
Return on Equity (ROE) | 7.10% | 4.71% | 14.74% | 8.16% | -10.53% | 8.37% |
Return on Assets (ROA) | 3.79% | 3.47% | 4.32% | 3.21% | 2.68% | 3.90% |
Return on Invested Capital (ROIC) | 5.35% | 4.52% | 7.02% | 5.25% | 5.35% | 6.42% |
Return on Capital Employed (ROCE) | 7.60% | 6.40% | 7.90% | 5.90% | 4.40% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.77% | 3.74% | 6.26% | 1.91% | -2.98% | 1.51% |
FCF Yield | 8.82% | 12.00% | 7.28% | 3.16% | 0.43% | 2.34% |
Dividend Yield | - | 1.48% | 1.17% | 0.73% | 0.90% | 0.57% |
Payout Ratio | - | 52.59% | 18.62% | 38.01% | - | 37.19% |
Buyback Yield / Dilution | 2.14% | 0.00% | 1.26% | -5.02% | 6.75% | -9.34% |
Total Shareholder Return | 2.14% | 1.48% | 2.43% | -4.29% | 7.66% | -8.77% |